🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We pride ourselves on our ability to #LearnAdaptWin, and what better time to do so than the new year, filled w/ exciting growth & learning opportunities for #TeamLantheus so we can #GoFurther for patients. #LantheusValues #NationalMentoringMonth

#NEWS: #Lantheus today announced an agreement to acquire Evergreen Theragnostics, Inc., a clinical-stage #radiopharmaceutical company. The all-cash transaction consists of an upfront payment of $250M & up to an additional $752.5M in potential milestone payments. This deal

#TeamLantheus recently attended the #HAI25 conference to learn about the latest updates in neurology. Read more from Luca Passamonti, MD, PhD, about his learnings from the conference & how #radiopharmaceuticals have the potential to revolutionize #AlzheimersDisease care. 🧠⬇️

#Lantheus is heading to SNMMI’s 2025 Mid-Winter & ACNM Annual Meeting tomorrow! We’re sponsoring this meeting & will have a symposium titled “PET/CT in Prostate Cancer Patients: Urology Case-Based Presentation” w/ speaker Steven Rowe, MD, PhD on 1/31 at 12:30 PM. Agenda:

#NEWS: #Lantheus today announced the appointment of Phuong Khanh (PK) Morrow, MD, a pharmaceutical executive & physician-scientist, to its Board of Directors. Ms. Morrow will serve as a member of the Board’s Science and Technology Committee. Full press release:

As we gear up for #AmericanHeartMonth kicking off tomorrow, let's #FBF to last year's Wear Red Day! ❤️ #TeamLantheus proudly wore red in support of raising awareness for heart disease and stroke, the leading cause of death among both men & women in the United States. Learn more:

Today, on #WorldCancerDay, we reflect on the positive impact we’ve had in the lives of millions of patients & continue to #FindFightFollow #prostatecancer & other cancers on their behalf. Learn more ➡️: bit.ly/3BS1GHW

#NEWS: #Lantheus today announced the presentation of new data at the 2025 ASCO Genitourinary Cancers Symposium. Full release: bit.ly/3Q5lgUs #GU25 #LNTH

Understanding the differences between Alzheimer’s & Dementia w/ Lewy bodies is crucial for early diagnosis & care. Learn more from the Alzheimer's Association. #WorldLewyBodyDay #FindFightFollow

This #NationalWearRedDay, join us & American Heart Association in rocking your red on behalf of women w/ #cardiovasculardisease! ❤️ At #Lantheus, our commitment to #hearthealth inspires us to #GoFurther for patients all year round. Learn more: bit.ly/3HoA1gS #FindFightFollow #CVD

We’ve been counting down to #NationalPeriodicTableDay today ever since the addition of our periodic table display in our Bedford, MA office! ⚛️ Hear from our VP of Isotope Strategy, John Wiggins, about how at #Lantheus, we’re illuminating innovation to #FindFightFollow disease

As we celebrate #BlackHistoryMonth, we reflect on the rich history, achievements & contributions of the Black community. This month, it's also crucial to address the need for heightened awareness for diseases, like #prostatecancer, that disproportionately affect the Black

Today, to celebrate the International Day of Women & Girls in Science, we chatted with numerous leaders on #TeamLantheus to hear about their experiences as women in science and why they're proud to be part of this field. Read their responses! 👇 #WomenInScience #OneLantheus

On 2/26 at 8:00 AM ET, tune in to our Q4 & Full Year 2024 Financial Results call & webcast. Tune in to hear our executives share updates at #Lantheus. Read the full press release: bit.ly/3EvDs7o #LNTH

Here is the answer for this week’s trivia: Black men are 60% more likely to be diagnosed with prostate cancer. Raising awareness and promoting early detection are vital steps in combating this issue. Let's use this month not only to celebrate the Black community but also to

This #ValentinesDay, we’re playing matchmaker to connect talented individuals w/ our passionate teams at #Lantheus. We’re dedicated to our Purpose to #FindFightFollow disease together. Find your perfect professional match by browsing our #openpositions on #TeamLantheus!

Our Q4 & Full Year 2024 Financial Results call is starting at 8:00 AM ET. Tune in to learn more from our #Lantheus Executive Team. Full press release: bit.ly/4gXO4Jy Listen to the webcast 🎙️: bit.ly/4ihdwe4 #LNTH #FindFightFollow

#NEWS: #Lantheus today announced the completion of its previously announced acquisition of Evergreen Theragnostics, Inc. & its late-stage PET diagnostic agent for #NETs, which complements Lantheus’ therapeutic agent. The acquisition also advances Lantheus’ capabilities w/ the

🎉 Congrats to #Lantheus’ own Ann Marie Dawidczyk, head of Market Access, on being elected recently to lead MITA’s PET Group. Ann Marie will serve as Chair in 2026 & was chosen for her #nuclearmedicine expertise. We’re glad to have her on #TeamLantheus and celebrate this